Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 227

The DOI matches its Crossref record.

Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer

Kawai, Hideki, Ishii, Akira, Washiya, Kiyotada, Konno, Toshiko, Kon, Hiroto, Yamaya, Chiharu, Ono, Iwao, Minamiya, Yoshihiro, Ogawa, Junichi · 2005 · Clinical Cancer Research

Abstract

Purpose: Estrogen receptor-α (ER-α) and -β (ER-β) play important roles in the carcinogenesis of breast tumors. Similarly, there have been several reports of ER expression in lung cancers, but the results have not been consistent, and the receptors' prognostic value remains unclear. Our goal was to investigate ER expression in non–small cell lung cancer (NSCLC) and to assess whether their expression correlates with prognosis. Experimental Design: ER expression was examined using immunohistochemical methods with sections from 132 resected NSCLC specimens. Kaplan-Meier survival curves were analyzed to determine the significance of ER expression in the prognosis of NSCLC patients. Results: ER-α was detected in the cytoplasm of 73% of the specimens analyzed, whereas ER-β was detected in the nucleus of 51%. ER-α expression correlated with poorer overall survival (P<0.001), as did the absence of ER-β expression (P = 0.048). Likewise, at histopathologic stage I, ER-α expression (P = 0.028) or the absence of ER-β (P = 0.037) correlated with a poorer prognosis, and ER-α(+)ER-β(−) patients had a significantly worse prognosis than ER-α(−)ER-β(+) patients (P = 0.00007). Multivariate Cox regression analysis revealed the absence of ER-β to be an independent factor predictive of poor disease outcome (hazard ratio, 1.9; 95% confidence interval, 1.1-3.4; P = 0.0264). Conclusions: ER-α expression and the absence of ER-β expression are associated with a poorer prognosis among NSCLC patients. In particular, the absence of ER-β could serve as a marker identifying patients at high risk even at an early clinical stage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-05-0200

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 227

Metadata

Authors
Kawai, H., Ishii, A., Washiya, K., Konno, T., Kon, H., Yamaya, C., Ono, I., Minamiya, Y., & Ogawa, J.
Venue
Clinical Cancer Research
Published
2005-07-15
Volume
11
Issue
14
Pages
5084-5089
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W1991378725
Cited by
227
References
0
FWCI
3.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-05-0200
The paper
Kawai, H., Ishii, A., Washiya, K., Konno, T., Kon, H., Yamaya, C., Ono, I., Minamiya, Y., & Ogawa, J. (2005). Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-05-0200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.